We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
153 result(s) found, displaying 91 to 100
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TRAJENTAMET 2.5 mg/850 mg linagliptin 2.5 mg / metformin hydrochloride 850 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TRAJENTAMET 2.5 mg/1000 mg linagliptin 2.5 mg / metformin hydrochloride 1000 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TRAJENTAMET 2.5 mg/1000 mg linagliptin 2.5 mg / metformin hydrochloride 1000 mg film-coated tablet bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TRAJENTAMET 2.5 mg/500 mg linagliptin 2.5 mg / metformin hydrochloride 500 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TRAJENTAMET 2.5 mg/850 mg linagliptin 2.5 mg / metformin hydrochloride 850 mg film-coated tablet bottle.
-
Cancellation by sponsorRequested by Boehringer Ingelheim Pty Ltd
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Idarucizumab
-
Cancellation by sponsorRequested by Boehringer Ingelheim Pty Ltd
-
Cancellation by sponsorRequested by Boehringer Ingelheim Pty Ltd
-
Cancellation by sponsorRequested by Boehringer Ingelheim Pty Ltd